Enterome’s GeneMark-HM software highlighted as the most accurate microbiome gene prediction software in peer-reviewed publication NAR Genomics and Bioinformatics

PARIS, June 16, 2021 /PRNewswire/ — ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code the molecular interactions in the gut microbiome impacting human health, announces that the powerful capabilities of its proprietary…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.